310 related articles for article (PubMed ID: 17425656)
1. Autoantibodies to plasminogen and tissue plasminogen activator in women with recurrent pregnancy loss.
Bu C; Zhang C; Li Z; Gao L; Xie Z; Cai G
Clin Exp Immunol; 2007 Jul; 149(1):31-9. PubMed ID: 17425656
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies in Argentine women with recurrent pregnancy loss.
Bustos D; Moret A; Tambutti M; Gogorza S; Testa R; Ascione A; Prigoshin N
Am J Reprod Immunol; 2006 Mar; 55(3):201-7. PubMed ID: 16451354
[TBL] [Abstract][Full Text] [Related]
3. IgG antibodies to plasminogen and their relationship to IgG anti-beta(2)-glycoprotein 1 antibodies and thrombosis.
Bu C; Li Z; Zhang C; Gao L; Cai G
Clin Rheumatol; 2008 Feb; 27(2):171-8. PubMed ID: 17646899
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to receptor induced neoepitopes of fibrinolytic proteins in rheumatic and vascular diseases.
Dominguez M; Cacoub P; Garcia de la Torre I; Piette TJ; Salazar-Paramo M; Godeau P; Angleés-Cano E
J Rheumatol; 2001 Feb; 28(2):302-8. PubMed ID: 11246666
[TBL] [Abstract][Full Text] [Related]
5. Anti-elastin antibodies and elastin turnover in normal pregnancy and recurrent pregnancy loss.
Konova E; Aleksovska T; Atanasova M; Georgieva M; Todorova K; Lukanov T; Shoenfeld Y
Am J Reprod Immunol; 2009 Feb; 61(2):167-74. PubMed ID: 19143680
[TBL] [Abstract][Full Text] [Related]
6. A case-control study on the association of idiopathic recurrent pregnancy loss with autoantibodies against beta2-glycoprotein I and annexin V.
Zammiti W; Mtiraoui N; Kallel C; Mercier E; Almawi WY; Mahjoub T
Reproduction; 2006 Apr; 131(4):817-22. PubMed ID: 16595732
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to tissue-type plasminogen activator in plasma from patients with primary antiphospholipid syndrome.
Cugno M; Dominguez M; Cabibbe M; Bisiani G; Galli M; Angles-Cano E; Agostoni A
Br J Haematol; 2000 Mar; 108(4):871-5. PubMed ID: 10792298
[TBL] [Abstract][Full Text] [Related]
8. Idiotypic and anti-idiotypic elastin autoantibodies: Implications for IVIg and pregnancy loss.
Konova E; Atanasova M; Stoykov S; Velkova A; Shoenfeld Y
J Autoimmun; 2007 Feb; 28(1):46-54. PubMed ID: 17178213
[TBL] [Abstract][Full Text] [Related]
9. Anti-vascular endothelial cell antibodies (AECA): comparison of two assay methods and clinical applications.
Meyer O; Kaiser P; Haim T; Edgell CJ; Pasquier C; de Bandt M; Bridey F; Sellak H; Lansaman J; Kahn MF
Rev Rhum Engl Ed; 1995 Dec; 62(11):737-47. PubMed ID: 8869215
[TBL] [Abstract][Full Text] [Related]
10. Assay of human tissue-type plasminogen activator (t-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies to t-PA.
Holvoet P; Cleemput H; Collen D
Thromb Haemost; 1985 Oct; 54(3):684-7. PubMed ID: 3937265
[TBL] [Abstract][Full Text] [Related]
11. Respective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. The Nimes Obstetricians and Haematologists (NOHA) Study.
Gris JC; Ripart-Neveu S; Maugard C; Tailland ML; Brun S; Courtieu C; Biron C; Hoffet M; Hédon B; Marès P
Thromb Haemost; 1997 Jun; 77(6):1096-103. PubMed ID: 9241739
[TBL] [Abstract][Full Text] [Related]
12. Characterization of monoclonal antibodies to human tissue-type plasminogen activator: catalytic inhibition and one-two chain discriminatory reactivities.
Stigbrand T; Frängsmyr L; Bergsdorf N; Wallen P
Thromb Haemost; 1989 Sep; 62(2):742-7. PubMed ID: 2479112
[TBL] [Abstract][Full Text] [Related]
13. Treatment with hyperbaric oxygen affects endothelial cell fibrinolysis.
Tjärnström J; Holmdahl L; Arnell P; Falkenberg M; Risberg B
Eur J Surg; 1999 Sep; 165(9):834-8. PubMed ID: 10533756
[TBL] [Abstract][Full Text] [Related]
14. Antiphosphatidylethanolamine antibodies in recurrent early pregnancy loss and mid-to-late pregnancy loss.
Sugi T; Matsubayashi H; Inomo A; Dan L; Makino T
J Obstet Gynaecol Res; 2004 Aug; 30(4):326-32. PubMed ID: 15238112
[TBL] [Abstract][Full Text] [Related]
15. Recurrent pregnancy loss and frequency of eight antiphospholipid antibodies and genetic thrombophilic factors in Czech women.
Subrt I; Ulcova-Gallova Z; Bibkova K; Micanova Z; Hejnalova M; Cerna M; Hradecky L; Novotny Z
Am J Reprod Immunol; 2008 Mar; 59(3):193-200. PubMed ID: 18275512
[TBL] [Abstract][Full Text] [Related]
16. Effect of the lupus anticoagulant on endothelial fibrinolytic activity in vitro.
Francis RB; Neely S
Thromb Haemost; 1989 Apr; 61(2):314-7. PubMed ID: 2501901
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies and prediction of reproductive failure.
Shoenfeld Y; Carp HJ; Molina V; Blank M; Cervera R; Balasch J; Tincani A; Faden D; Lojacono A; Doria A; Konova E; Meroni PL
Am J Reprod Immunol; 2006; 56(5-6):337-44. PubMed ID: 17076678
[TBL] [Abstract][Full Text] [Related]
18. Oxidized LDL, anti-oxidized LDL and anti-annexin A5 antibodies in primary antiphospholipid syndrome.
Becarevic M; Singh S; Majkic-Singh N
Clin Lab; 2008; 54(3-4):97-101. PubMed ID: 18630740
[TBL] [Abstract][Full Text] [Related]
19. Cytokines in recurrent pregnancy loss.
Daher S; de Arruda Geraldes Denardi K; Blotta MH; Mamoni RL; Reck AP; Camano L; Mattar R
J Reprod Immunol; 2004 Jun; 62(1-2):151-7. PubMed ID: 15288190
[TBL] [Abstract][Full Text] [Related]
20. The clinical significance of autoantibodies directed against prothrombin in primary antiphospholipid syndrome.
Hoxha A; Ruffatti A; Pittoni M; Bontadi A; Tonello M; Salvan E; Plebani M; Punzi L
Clin Chim Acta; 2012 May; 413(9-10):911-3. PubMed ID: 22349599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
